Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 162Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Sanofi

02 2ANDA Repository

03 2Actavis Inc

04 4Adcock Ingram

05 2Aeron Remedies

06 2Alkem Laboratories

07 4Ascend Labs

08 2Associated Biotech

09 1Athens Life Science

10 8Aurobindo Pharma Limited

11 3BRUNO FARMACEUTICI SpA

12 2Chartwell Pharmaceuticals llc

13 5DEVATS INDIA

14 10Daiichi Sankyo

15 2Embiotic Laboratories

16 10Gracure Pharmaceuticals Limited

17 4Health Biotech

18 3Hiral Labs

19 2Jodas Expoim Pvt. Ltd

20 2Kniss Laboratories

21 3Medreich

22 5Nectar Lifesciences

23 3Nishchem International Pvt. Ltd

24 3Nobel Ilac Sanayii Ve Ticaret A.S.

25 2Orchid Pharma

26 4Pfizer Inc

27 4Pharma Dynamics

28 7RANBAXY LABORATORIES LIMITED

29 3SCHARPER SpA

30 17Sandoz B2B

31 3Scharper

32 1Shaimil Laboratories

33 1Smith & Kenner Pharmaceuticals

34 3So.Se.Pharm

35 4Sun Pharmaceutical Industries Limited

36 2Theon Pharmaceuticals

37 2Umedica Laboratories

38 4Unosource Pharma

39 7Viatris

40 6World Medicine

41 2XL Laboratories Private Limited

42 1ZOETIS MANUFACTURING ITALIA S.R.L. IT 95121 Catania

43 4Zeiss Pharma

44 6Zim Laboratories

45 3Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 0.8% 100Ml Oral Use

Dosage Strength : BB os suspe grat 100 ml 40 mg/5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

02

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 100Mg 12 Combined Oral Use

Dosage Strength : 12 cpr riv 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

03

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 200Mg 6 Combined Oral Use

Dosage Strength : 6 cpr riv 200 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

04

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Granulate For Oral Suspension

Dosage Strength : 0.80%

Packaging : 100 ML 0.8% - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

05

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Film-Coated Tablets

Dosage Strength : 100 mg

Packaging : 12 UNITS 100 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

06

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Film-Coated Tablets

Dosage Strength : 200 mg

Packaging : 6 UNITS 200 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

07

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Cefpodoxime

Brand Name : Orelox 200 mg

Dosage Form : TAB

Dosage Strength : 200mg

Packaging : 10X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

08

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Cefpodoxime

Brand Name : Orelox 100

Dosage Form : TAB

Dosage Strength : 100mg

Packaging : 10X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

09

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Cefpodoxime

Brand Name : Orelox Junior

Dosage Form : SUS

Dosage Strength : 40mg/5ml

Packaging : 50X1mg/5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

10

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Cefpodozime

Brand Name : Orelox Junior

Dosage Form : SUS

Dosage Strength : 40mg/5ml

Packaging : 100X1mg/5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

11

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2007-11-14

Application Number : 65388

Regulatory Info : RX

Registration Country : USA

blank

12

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2007-11-14

Application Number : 65388

Regulatory Info : RX

Registration Country : USA

blank

13

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2007-06-11

Application Number : 65370

Regulatory Info : RX

Registration Country : USA

blank

14

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2007-06-11

Application Number : 65370

Regulatory Info : RX

Registration Country : USA

blank

15

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 50MG BASE/5ML

Packaging :

Approval Date : 2007-06-08

Application Number : 65409

Regulatory Info : RX

Registration Country : USA

blank

16

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 100MG BASE/5ML

Packaging :

Approval Date : 2007-06-08

Application Number : 65409

Regulatory Info : RX

Registration Country : USA

blank

17

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : BANAN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 1992-08-07

Application Number : 50687

Regulatory Info : DISCN

Registration Country : USA

blank

18

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : BANAN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 1992-08-07

Application Number : 50687

Regulatory Info : DISCN

Registration Country : USA

blank

19

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : BANAN

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 100MG BASE/5ML

Packaging :

Approval Date : 1992-08-07

Application Number : 50688

Regulatory Info : DISCN

Registration Country : USA

blank

20

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : BANAN

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 50MG BASE/5ML

Packaging :

Approval Date : 1992-08-07

Application Number : 50688

Regulatory Info : DISCN

Registration Country : USA

blank

21

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : VANTIN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-08-07

Application Number : 50674

Regulatory Info : DISCN

Registration Country : USA

blank

22

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : VANTIN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-08-07

Application Number : 50674

Regulatory Info : DISCN

Registration Country : USA

blank

23

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : VANTIN

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 50MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-08-07

Application Number : 50675

Regulatory Info : DISCN

Registration Country : USA

blank

24

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : VANTIN

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 100MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1992-08-07

Application Number : 50675

Regulatory Info : DISCN

Registration Country : USA

blank

25

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2008-05-28

Application Number : 65462

Regulatory Info : RX

Registration Country : USA

blank

26

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2008-05-28

Application Number : 65462

Regulatory Info : RX

Registration Country : USA

blank

27

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 50MG BASE/5ML

Packaging :

Approval Date : 2002-05-31

Application Number : 65082

Regulatory Info : DISCN

Registration Country : USA

blank

28

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 100MG BASE/5ML

Packaging :

Approval Date : 2002-05-31

Application Number : 65082

Regulatory Info : DISCN

Registration Country : USA

blank

29

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2003-08-20

Application Number : 65083

Regulatory Info : DISCN

Registration Country : USA

blank

30

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2003-08-20

Application Number : 65083

Regulatory Info : DISCN

Registration Country : USA

blank